In a recent study posted to the bioRxiv* pre-print server, a team of researchers used an assay toolset for discovering new transmembrane protease serine 2 (TMPRSS2) inhibiting drug repurposing ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to affect cancer patients at a higher rate than healthy people. The role played by the host enzyme TMPRSS2 in infection ...
TMPRSS2 is a host serine protease that helps influenza viruses and SARS-CoV-2 enter cells, making it an attractive target for antiviral intervention. Rather than blocking the protein after it is ...
How exactly do SARS-CoV-2 particles enter host cells? An international team led by Dr. Richard Brown from Dr. Daniel Todt's Computational Virology group at the Department of Molecular and Medical ...
Validation of a panel of cell-cycle progression genes for improved risk stratification in a contemporary radical prostatectomy cohort. Background: Approximately 50% of prostate cancers (PC) contain ...
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors TMPRSS2-ERG gene fusions are frequently found in ...
A common genetic change is associated with a reduced risk of severe COVID-19 infection, highlighting a potential target for drugs in early treatment. A team led by Imperial College London researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results